期刊名称：JOURNAL OF CELL COMMUNICATION AND SIGNALING
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
ISSN: 1873-9601 (Print) 1873-961X (Online)
- Addresses all aspects of cell-cell, cell-matrix communication, and intracellular signaling
- Covers receptors, ligands, and other biomolecules participating in cellular signaling pathways
The Journal of Cell Communication and Signaling provides a forum for fundamental and translational research. In particular, it publishes papers discussing intercellular and intracellular signaling pathways that are particularly important to understand how cells interact with each other and with the surrounding environment, and how cellular behavior contributes to pathological states. JCCS encourages the submission of research manuscripts, timely reviews and short commentaries discussing recent publications, key developments and controversies.
Research manuscripts can be published under two different sections :.
In the Pathology and Translational Research Section (Section Editor Andrew Leask) , manuscripts report original research dealing with celllular aspects of normal and pathological signaling and communication, with a particular interest in translational research.
In the Molecular Signaling Section (Section Editor Satoshi Kubota) manuscripts report original signaling research performed at molecular levels with a particular interest in the functions of intracellular and membrane components involved in cell signaling.
The Review Section (Section Editor David Brigstock) is a venue for publication of review articles that summarize recent advances and discoveries, identify gaps and debates, and outline future directions in all aspects of cell signaling and communication. The Journal is particularly interested in focused and authoratative mini-reviews that will allow the reader to gain a rapid understanding of the material presented. Mini-reviews should not exceed 5000 words, excluding the abstract and bibliography. No more than 80 references should be cited. Inclusion of figures to help summarize the major concepts is encouraged. Authors are requested to contact the Section Editor with a proposed outline of their article before submission so that its suitability for publication in the journal can be assessed.
The ‘At the Forefront of Unforeseen Science’ section (Section Editor Bernard Perbal publishes peer-reviewed articles reporting on groundbreaking discoveries that promise to have an impact on the future of mankind. The manuscripts should be written in the form of a concise analysis and review of exciting advances in any scientific field that will offer novel perspectives that could open new avenues for research and applications
The Bits & Bytes section (Section Editors Andrew Leask and Herman Yeger) provides a forum for the rapid distribution of short commentaries on recent publications and news that are of interest to the scientific community. These commentaries also appear on the Web site of the International CCN Society (http://ccnsociety.com) as soon as they are accepted.
Letters to the Editor, which should be original research manuscripts reporting findings of wide interest to the scientific community. Letters typically do not exceed 2-4 pages and report early but ground breaking studies that deserve accelerated processing. The letters undergo strict peer review. The number of figures and or tables is limited to 3. The text is not to exceed 2000 words, and reference should be kept to a minimum. The preliminary review process is conducted under the responsibility of the Editor in Chief. Manuscripts that do not comply with the 'Letter' requirements are transferred to regular section editors. , which should be original research manuscripts reporting findings of wide interest to the scientific community. Letters typically do not exceed 2-4 pages and report early but ground breaking studies that deserve accelerated processing. The letters undergo strict peer review. The number of figures and or tables is limited to 3. The text is not to exceed 2000 words, and reference should be kept to a minimum. The preliminary review process is conducted under the responsibility of the Editor in Chief. Manuscripts that do not comply with the 'Letter' requirements are transferred to regular section editors.
About the Editors:
Bernard Perbal : http://ccnsociety.com/about_the_iccns/president.html
Andrew Leask : http://ccnsociety.com/about_the_iccns/member_a_leask.html
Satoshi Kubota : http://ccnsociety.com/about_the_iccns/member_s_kubota.html
David Brigstock : http://ccnsociety.com/about_the_iccns/member_d_brigstock.html
General Details on the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online and Print Color Images
- Optional Open Access Publication Fee (APC) – USD 3000,- / Euro 2200,-
Related subjects » Biomedical Sciences - Cell Biology
Abstracted/Indexed in
Science Citation Index Expanded (SciSearch), PubMed, PubMedCentral, SCOPUS, EMBASE, Google Scholar, CSA, Academic OneFile, AGRICOLA, Biological Abstracts, BIOSIS, EMBiology, Expanded Academic, OCLC, SCImago, Summon by ProQuest
Aims and Scope
The Journal of Cell Communication and Signaling provides a forum for fundamental and translational research. In particular, it publishes papers discussing intercellular and intracellular signaling pathways that are particularly important to understand how cells interact with each other and with the surrounding environment, and how cellular behavior contributes to pathological states. JCCS encourages the submission of research manuscripts, timely reviews and short commentaries discussing recent publications, key developments and controversies.
Research manuscripts can be published under two different sections :.
In the Pathology and Translational Research Section (Section Editor Andrew Leask) , manuscripts report original research dealing with celllular aspects of normal and pathological signaling and communication, with a particular interest in translational research.
In the Molecular Signaling Section (Section Editor Satoshi Kubota) manuscripts report original signaling research performed at molecular levels with a particular interest in the functions of intracellular and membrane components involved in cell signaling.
The Review Section (Section Editor David Brigstock) is a venue for publication of review articles that summarize recent advances and discoveries, identify gaps and debates, and outline future directions in all aspects of cell signaling and communication. The Journal is particularly interested in focused and authoratative mini-reviews that will allow the reader to gain a rapid understanding of the material presented. Mini-reviews should not exceed 5000 words, excluding the abstract and bibliography. No more than 80 references should be cited. Inclusion of figures to help summarize the major concepts is encouraged. Authors are requested to contact the Section Editor with a proposed outline of their article before submission so that its suitability for publication in the journal can be assessed.
The ‘At the Forefront of Unforeseen Science’ section (Section Editor Bernard Perbal publishes peer-reviewed articles reporting on groundbreaking discoveries that promise to have an impact on the future of mankind. The manuscripts should be written in the form of a concise analysis and review of exciting advances in any scientific field that will offer novel perspectives that could open new avenues for research and applications
The Bits & Bytes section (Section Editors Andrew Leask and Herman Yeger) provides a forum for the rapid distribution of short commentaries on recent publications and news that are of interest to the scientific community. These commentaries also appear on the Web site of the International CCN Society (http://ccnsociety.com) as soon as they are accepted.
Instructions to Authors
14-05-14_JCCS_Instructions_for_Authors.pdf
Editorial Board
Editor-in-Chief
Bernard Perbal "President of the International CCN Society"
Section Editors
Pathology and Translational Research
Andrew Leask "University of Western Ontario, Ontario, Canada"
Molecular Signaling
Satoshi Kubota “Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan”
Reviews
David Brigstock “Children's Research Institute, Columbus, USA”
Bits and Bytes
Andrew Leask "University of Western Ontario, Ontario, Canada"
Herman Yeger "The Hospital for Sick Children, Toronto, Canada"
Administrative Assistant
Annick Perbal
Editorial Board
David Abraham "University College London, London, UK"
K. Ravi Acharya "University of Bath, Bath, UK"
Sushanta Banerjee "University of Kansas Medical Center, Kansas City MO, USA"
George Bou-Gharios "Imperial College London, London, UK"
Enrique Brandan "Pontificia Universidad Católica de Chile, Chile"
Rolf Brekken "The University of Texas Southwestern Medical Center, Dallas TX, USA"
Ernesto Canalis "St Francis Hospital and Medical Center, Hartford CT, USA"
John Castellot "Tufts University, Boston MA, USA"
Carlo Croce "Ohio State University Medical Center, Columbus OH, USA"
Mick Dashwood "Royal Free Hospital, London, UK"
Marc Diederich "Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg"
Hung Fan "University of California at Irvine, Irvine CA, USA"
Gary Fisher "University of Michigan Mecial School, Ann Arbor MI, USA"
Roel Goldschmeding "University Medical Center Utrecht, Utrecht, the Netherlands"
Douglas Hamilton "University of Western Ontario, Ontario, Canada"
Masato Hirata "Kyushu University, Fukuoka, Japan"
Sandra Irvine "Queen's University Belfast, Belfast, Northern Ireland"
Ken-Ichi Katsube "Graduate School of Tokyo Medical and Dental University, Tokyo, Japan"
Celina Kleer "University of Michigan, Ann Arbor MI, USA"
Heinrich Kovar "Children's Cancer Research Institute, Vienna, Austria"
Akira Kudo "Tokyo Institute of Technology, Tokyo, Japan"
Robert Lafyatis "Boston University, Boston MA, USA"
Paul Lasko "McGill University, Montreal QC, Canada"
Lester Lau "University of Illinois, Chicago IL, USA"
Jack Lawler "Beth Israel Deaconess Medical Center, Boston MA, USA"
Karen Lyons "UCLA, Los Angeles CA, USA"
Roger Mason "Imperial College London, London, UK"
Kohei Miyazono "University of Tokyo, Tokyo, Japan"
Joanne E. Murphy-Ullrich "University of Alabama at Birmingham, Birmingham AL, USA"
Christian Naus "University of British Columbia, Vancouver BC, Canada"
Kunimasa Ohta “Kumamoto University, Kumamoto, Japan”
Maurizio Pacifici "Thomas Jefferson University, Philadelphia PA, USA"
Anie Philip "McGill University, Montreal QC, Canada"
Lynne-Marie Postovit "University of Western Ontario, London ON, Canada"
Laure Rittié “University of Michigan, Ann Arbor, USA”
David D. Roberts "National Institutes of Health, Bethesda MD, USA"
Lars Savendahl "Karolinska Institute, Stockholm, Sweden"
Katia Scotlandi "Istituti Ortopedici Rizzoli, Bologna, Italy"
Peter Siegel "McGill University, Montreal QC, Canada"
Ulf Smith "University of Gothenburg, Sweden"
Shogo Takashiba "Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan"
Masaharu Takigawa "Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan"
Philip C. Trackman "Boston University, Boston MA, USA"
Stephen Twigg "Royal Prince Alfred Hospital, Sydney, Australia"
Toshimitsu Uede "Hokkaido University, Sapporo, Japan"
Denys Wheatley "BioMedES Ltd., Aberdeenshire, UK"
Toshiyuki Yoneda "University of Texas Health Science Center at San Antonio, San Antonio TX, USA"
Advisory board
Robert Baxter “University of Sydney, St Leonards, Australia”
Edward Calabrese “University of Massachusetts, Amherst MA,USA”
Benoit de Crombrugghe "MD Anderson Cancer Center, Houston TX, USA"
Meenhard Herlyn "The Wistar Institute, Philadelphia PA, USA"
Piero Picci "Istituti Rizzoli, Bologna, Italy"
Bernard Roizman "University of Chicago, Chicago IL, USA"
|
